Related Experiment Video
Updated: Aug 3, 2026
07:55
A Multi-Parametric Islet Perifusion System within a Microfluidic Perifusion Device
Published on: January 27, 2010
Grading system to assess clinical performance of closed-loop glucose control
Ludovic J Chassin1, Malgorzata E Wilinska, Roman Hovorka
1Diabetes Modelling Group, Department of Paediatrics, University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom.
Diabetes Technology & Therapeutics
|March 2, 2005
Summary
A new grading system assesses closed-loop glucose control systems for type 1 diabetes. This system, using grades A-F, quantifies control levels and guides therapeutic actions, enhancing patient safety and treatment efficacy.
Area of Science:
- Endocrinology and Metabolic Diseases
- Biomedical Engineering
- Artificial Intelligence in Medicine
Background:
- Type 1 diabetes management increasingly utilizes closed-loop control systems.
- Continuous glucose sensing advancements have enabled sophisticated glucose controllers.
- Existing measures for glucose control lack comprehensive clinical assessment criteria.
Purpose of the Study:
- To introduce a novel grading system for clinical assessment of closed-loop glucose control systems.
- To evaluate the efficacy and safety of glucose controllers, including model predictive controllers.
- To complement existing metrics for glucose control in type 1 diabetes.
Main Methods:
- Development of a six-grade (A-F) system evaluating glucose control and therapeutic intervention.
- Categorization of grades based on control level and need for corrective actions (outside-meal and postprandial).
- Quantification of time spent in each grade, exemplified with in silico data from a model predictive controller.
Main Results:
- The grading system categorizes control into excellent (A), good (B), suboptimal (C), poor (D), very poor (E), and life-threatening (F).
- Grades A and B indicate effective control without intervention; C and D suggest intervention is needed.
- Grades E and F signify critical situations requiring immediate action or external support.
Conclusions:
- The proposed grading system offers a robust method for assessing the clinical efficacy and safety of glucose controllers.
- This system provides valuable insights beyond traditional glucose control metrics.
- It aids in standardizing the evaluation of artificial pancreas technologies for type 1 diabetes.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...